Genetics of migraine

Cover Page


Cite item

Full Text

Abstract

Hereditary factor increases the risk of migraine and underlies in many respects the development of symptoms and the disease course. Last years, basic genetic studies in migraine resulted in impressive achievements, which gave the key to understanding pathophysiological processes in this disease. At the same time, many questions remain unanswered. Most interesting is the search for genetic markers of migraine and their phenotypical correlates. From practical viewpoint, equally promising in migraine heredity studies are pharmacogenetic aspects, namely, identification of genetic predictors of the efficacy of particular medications. In this review, modern approaches to genetic studies in migraine are discussed, and presently known genetic biomarkers and their possible role in the disease development are presented.

 
 

About the authors

Yu. E. Azimova

1st Moscow State Medical University named after I.M. Sechenov

Email: platonova@neurology.ru
Россия, Moscow

G. R. Tabeeva

1st Moscow State Medical University named after I.M. Sechenov

Email: platonova@neurology.ru
Россия, Moscow

E. A. Klimov

N.I. Vavilov Institute of General Genetics, Russian Academy of Sciences

Author for correspondence.
Email: platonova@neurology.ru
Россия, Moscow

References

  1. Амелин А.В., Игнатов Ю.Д., Скоромец А.А. Мигрень (патогенез, клиника и лечение). СПб.: Медицинское издательство, 2001.
  2. Вельтищев Ю.Е., Темин П.А. Митохондриальные болезни. Наследственные болезни нервной системы: руководство для врачей. В кн.: Вельтищев Ю.Е., Темин П.А. (ред.). М.: Mедицина, 1998: 346–471.
  3. Второй классификационный комитет. Международная классификация головной боли, 2-е издание. Международное общество головной боли, 2003. Пер. Осиповой В.В., Вознесенской Т.Г. А.О. «Гедеон Рихтер», 2003.
  4. Иллариошкин С.Н. Руденская Г.Е., Иванова-Смоленская И.А. и др. Наследственные атаксии и параплегии. М.: МЕДпресс-информ, 2006.
  5. Akerman S., Goatsby P.J. Dopamine and migraine: biology and clinical implication. Cephalalgia 2007; 27: 1308–1314.
  6. Asuni C., Cherchi A., Congiu D. et al. Association study between clinical response to rizatriptan and some candidate genes. J. Headache Pain 2007; 8: 185–189.
  7. Barbas N.R., Schuyler E.A. Heredity, genes and headache. Seminars in Neurology 2006; 26: 507–514.
  8. Borroni B., Rao R., Liberini P. et al. Endothelial nitric oxide synthase (Glu298Asp) polymorphism is an independent risk factor for migraine with aura. Headache 2006; 46: 1575–1579.
  9. Corral J., Iniesta J.A., Gonzales-Conejero R. et al. Migraine and prothrombotic risk factors. Cephalalgia 1998; 18: 257–260.
  10. De Fusco M., Marconi R., Silvestri L. et al. Haploinsufficiency of ATP1A2 encoding the Na/K pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet. 2003; 33: 192–196.
  11. De Tommaso M., Difruscolo O., Sardaro M. et al. Influence of MTHFR genotype on contingent negative variation and MRI abnormalities in migraine. Headache 2007; 47: 253–265.
  12. De Vries B., Haan J., Frants R.R. et al. Genetic biomarkers for migraine. Headache 2006; 46: 1059–1068.
  13. Dichgans M., Freilinger T., Eckstein G. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 2005; 336: 371–377.
  14. Erdal N., Herken H., Yilmaz M. et al. The A218C polymorphism of tryptophan hydroxylase gene and migraine. J. Clin. Neurosci. 2007; 14: 249–251.
  15. Gursoy-Ozdemir Y., Qiu J., Matsuoka N. et al. Cortical spreading depression activates and upregulates MMPP9. J. Clin. Invest. 2004; 113: 1447–1455.
  16. Hademenos G.J., Alberts M.J., Award I. et al. Advances in the genetics of cerebrovascular disease and stroke. Neurology 2001; 56: 997–1008.
  17. Hagen K., Pettersen E., Stovner L.J. et al. The association between headache and Val158Met polymorphism in the catechol-O-methyll transferase gene: the HUNT Study. J. Headache Pain 2006; 7: 70–74.
  18. Hamel E. Serotonin and migraine: biology and clinical implication. Cephalalgia 2007; 27: 1295–1300.
  19. Hohoff C., Marziniak M., Lesch K..P. et al. An adenosine A2A receptor gene halotype is associated with migraine with aura. Cephalalgia 2007; 27: 177–181.
  20. Hovatta I., Kallela M., Farkkila M. et al. Familial migraine: exclusion of the susceptibility gene from the reported locus of familial hemiplegic migraine of 19p. Genomics 1994; 23: 707–709.
  21. Joutel A., Bousser M.G., Biousse V. et al. A gene for familial hemiplegic migraine maps to chromosome 19. Nat. Genet. 1993; 5: 40–45.
  22. Kara I., Ozkok E., Aydin M. et al. Combined effects of ACE and MMPP3 polymorphisms on migraine development. Cephalalgia 2007; 27: 235–243.
  23. Kara I., Sazci A., Ergul E. et al. Association of the C677 and A1298C polymorphisms in the 5, 10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain. Res. Mol. Brain. Res. 2003; 111: 84–90.
  24. Kaunisto M.A., Kallela M., Hamalainen E. et al. Testing variants of the MTHFR and ESR1 genes in 1798 Finnish individuals fails to confirm the association with migraine with aura. Cephalalgia 2006; 26: 1462–1472.
  25. Kim N.K., Choi B.O., Jung W.S. et al. Hyperhomocysteinemia as an independent risk for silent brain infarction. Neurology 2003; 61: 1595–1599.
  26. Kirchmann M., Thompsen L.L., Olsen J. The CACNA1A and ATP1A2 genes are not involved in dominantly inherited migraine with aura. Am. J. Med. Genet. B., Neuropsychiatr. Genet. 2006; 141: 250–256.
  27. Kotoni K., Shimomura T., Shimomura F. et al. A polymorphism in the serotonin transporter gene regulatory region and frequency of migraine attack. Headache 2002; 42: 893–895.
  28. Kowa H., Yasui K., Takeshima T. et al. The homozygous C677 mutation in methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am. J. Med. Genet. 2000; 96: 762–764.
  29. Kusumi M., Ishizaki K., Kowa H. et al. Glutathione S-transferase polymorphisms: susceptibility to migraine without aura. Eur. Neurol. 2003; 49: 218–222.
  30. Lea R.A., Ovcaric M., Sundholm J. et al. Genetic variants of angiotensin conversing enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility. Brain Res. Mol. Brain. Res. 2005; 136: 112–117.
  31. Lea R.A., Ovcaric M., Sundholm J. et al. The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Medicine. 2004; 2: 1741–1750.
  32. Lee K..A., Jang S.Y., Sohn K..M. et al. Association between a polymorphism in the lymphotoxina promoter region and migraine. Headache 2007; 47: 1056–1062.
  33. Leira R., Sobrino T. et al. MMPP9 immunoreactivity in acute migraine. Headache 2007; 47: 698–702.
  34. Magis D., Allena M., Coppola G. et al. Search for correlations between genotypes and electrophysiological patterns in migraine: the MTHFR C677T polymorphism and visual evoked potentials. Cephalalgia 2007; 27: 1142–1147.
  35. Marziniak M., Mossner R., Schmitt A. et al. A functional serotonin transporter gene polymorphism is associated with migraine with aura. Neurology 2005; 64: 157–159.
  36. May A., Ophoff R.A., Terwindt G.M. et al. Familial hemiplegic migraine locus on 19p13 is involved in the common forms of migraine with and without aura. Hum. Genet. 1995; 96: 604–608.
  37. McCarthy L.C., Hosford D.A., Riley J.H. et al. Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine. Genomics 2001; 78: 135–149.
  38. Mehrotra S., Vanmolkot K.R., Frants R.R. et al. The phe-1244Cys and AA161T variants of the human 55HT1B receptor gene are not major determinants of the clinical response to sumatriptan. Headache 2007; 47: 711–716.
  39. Moschiano F., D’Amico D., Ciusani E. et al. Coagulation abnormalities in migraine and ischaemic cerebrovascular disease: a link between migraine and ischaemic stroke. Neurol. Sci. 2004; 25 (suppl.3.): 126–128.
  40. Moskowitz M.A. Genes, proteases, cortical spreading depression and migraine: impact on pathophysiology and treatment. Functional Neurology 2007; 22: 133–136.
  41. Noble-Topham S.E., Dyment D.A., Cader M.Z. et al. Migraine with aura is not linked to the FHM gene CACNA1A or chromosomal region, 19p13. Neurology 2002; 59: 1099–1101.
  42. Nyholt D.R., Lea R.A., Goadsby P.J. et al. Familial typical migraine: linkage to chromosome 19p13 and evidence for genetic heterogeneity. Neurology 1998; 50: 1428–1432.
  43. Ophoff R.A., Terwindt G.M., Vergouwe M.N. et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996; 87: 543–552.
  44. Oterino A., Valle N., Bravo Y. et al. MTHFR T677 homozygosis influences the presence of aura in migreneurs. Cephalalgia 2004; 24: 491–494.
  45. Oterino A., Ruiz-Alegria C., Castillo J. et al. GNAS 1 T393C polymorphism is associated with migraine. Cephalalgia 2007; 27: 429–434.
  46. Pinessi L., Binello E., De Martino P. et al. The 1246G →A polymorphism of the HCRTR2 gene is not associated with migraine. Cephalalgia 2007; 27: 945–949.
  47. Rainero I., Rubino E., Rivoiro C. et al. Haemochromatosis gene (HFE) polymorphisms and migraine: an association study. Cephalalgia 2007; 27: 9–13.
  48. Rainero I, Grimaldi L, Salani G, et al. Association between the tumor necrosis factor-alpha 308 G/A gene polymorphism and migraine. Neurology 2004; 62: 141–43.
  49. Russell M.B., Olesen J. Increased familial risk and evidence of genetic factor in migraine. BMJ 1995; 311: 541–544.
  50. Scher A.I., Terwindt G.M., Verschuren W.M. et al. Migraine and MTHFR C677 genotype in a popular-based sample. Ann. Neurol. 2006; 59: 372–375.
  51. Shepherd A.G., Lea R.A., Hutchins C. et al. Dopamine receptor genes and migraine with and without aura: an association study. Headache 2002; 42: 346–351.
  52. Stewart W.F., Bigal M.E., Kolodner K. et al. Familial risk of migraine: variation by proband age at onset and headache severity. Neurology 2006; 66: 344–348.
  53. Storer R.J., Goadsby P.J. Microiontophoretic application of serotonin agonists inhibits trigeminal cell firing in the cat. Brain 1997; 120: 2171–2177.
  54. Terwindt G.M., Ophoff R.A., van Eijk R. et al. Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura. Neurology 2001; 56: 1028–1032.
  55. Van de Ven R.C.G., Kaja S., Plomp J.J. et al. Genetic models of migraine. Arch Neurol. 2007; 64: 643–646.
  56. Wessman M., Terwindt G.M., Kaunisto M. et al. Migraine: a complex genetic disorder. Lancet Neurol. 2007; 6: 521–532.
  57. Yilmaz M., Erdal M.E., Herken H. et al. Significance of serotonin transporter gene polymorphism in migraine. J. Neurol. Sci. 2001; 186: 27–30.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2008 Azimova J.E., Tabeeva1 G.R., Klimov E.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-83204 от 12.05.2022.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies